Literature DB >> 20084500

[New stent developments for peripheral arterial occlusive disease].

G Tepe1.   

Abstract

Infrainguinal peripheral occlusive disease is increasingly being treated by endovascular techniques. Bare metal stainless steel, self-expanding nitinol stents, drug-eluting and covered stents (stent grafts) are becoming increasingly more important adjuncts to percutaneous translumninal angioplasty in the treatment of peripheral artery disease. In this article the available evidence supporting the use of stents in the femoropopliteal and tibial arteries will be described as well as their limitations. Future stent developments will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20084500     DOI: 10.1007/s00117-009-1915-y

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  19 in total

1.  One year outcome after primary stenting of infrapopliteal lesions with the Chromis Deep stent in the management of critical limb ischaemia.

Authors:  Koen Deloose; Marc Bosiers; Patrick Peeters
Journal:  EuroIntervention       Date:  2009-08       Impact factor: 6.534

2.  Comparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructions.

Authors:  Dierk Scheinert; Mathias Ulrich; Susanne Scheinert; Jacqueline Sax; Sven Bräunlich; Giancarlo Biamino
Journal:  EuroIntervention       Date:  2006-08       Impact factor: 6.534

Review 3.  Current state of endovascular treatment of femoro-popliteal artery disease.

Authors:  Thomas Zeller
Journal:  Vasc Med       Date:  2007-08       Impact factor: 3.239

4.  Prevalence and clinical impact of stent fractures after femoropopliteal stenting.

Authors:  Dierk Scheinert; Susanne Scheinert; Jacqueline Sax; Christopher Piorkowski; Sven Bräunlich; Matthias Ulrich; Giancarlo Biamino; Andrej Schmidt
Journal:  J Am Coll Cardiol       Date:  2005-01-18       Impact factor: 24.094

Review 5.  Drug-eluting stents for infrainguinal occlusive disease: progress and challenges.

Authors:  Gunnar Tepe
Journal:  Semin Vasc Surg       Date:  2006-06       Impact factor: 1.000

6.  Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery.

Authors:  Martin Schillinger; Schila Sabeti; Christian Loewe; Petra Dick; Jasmin Amighi; Wolfgang Mlekusch; Oliver Schlager; Manfred Cejna; Johannes Lammer; Erich Minar
Journal:  N Engl J Med       Date:  2006-05-04       Impact factor: 91.245

7.  Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST).

Authors:  Hans Krankenberg; Michael Schlüter; Hermann J Steinkamp; Karlheinz Bürgelin; Dierk Scheinert; Karl-Ludwig Schulte; Erich Minar; Patrick Peeters; Marc Bosiers; Gunnar Tepe; Bernhard Reimers; Felix Mahler; Thilo Tübler; Thomas Zeller
Journal:  Circulation       Date:  2007-06-25       Impact factor: 29.690

8.  Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study.

Authors:  Marc Bosiers; Giovanni Torsello; Hans-Martin Gissler; Johannes Ruef; Stefan Müller-Hülsbeck; Thomas Jahnke; Patrick Peeters; Kim Daenens; Johannes Lammer; Herman Schroë; Klaus Mathias; Renate Koppensteiner; Frank Vermassen; Dierk Scheinert
Journal:  J Endovasc Ther       Date:  2009-06       Impact factor: 3.487

9.  Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease.

Authors:  Richard R Saxon; Michael D Dake; Robert L Volgelzang; Barry T Katzen; Gary J Becker
Journal:  J Vasc Interv Radiol       Date:  2008-04-10       Impact factor: 3.464

10.  AMS INSIGHT--absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis.

Authors:  Marc Bosiers; Patrick Peeters; Olivier D'Archambeau; Jeroen Hendriks; Ernst Pilger; Christoph Düber; Thomas Zeller; Andreas Gussmann; Paul N M Lohle; Erich Minar; Dierk Scheinert; Klaus Hausegger; Karl-Ludwig Schulte; Jürgen Verbist; Koen Deloose; J Lammer
Journal:  Cardiovasc Intervent Radiol       Date:  2008-12-18       Impact factor: 2.740

View more
  1 in total

1.  Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.

Authors:  Sang Ho Park; Seung Woon Rha; Cheol Ung Choi; Eung Ju Kim; Dong Joo Oh; Yun Hyeong Cho; Woong Gil Choi; Seung Jin Lee; Yong Hoon Kim; Seung Hyuk Choi; Won Ho Kim; Ki Chang Kim; Jang Hyun Cho; Joo Han Kim; Sang Min Kim; Jang Ho Bae; Jung Min Bong; Won Yu Kang; Ju Yeol Baek; Jae Bin Seo; Woo Young Chung; Mahn Won Park; Sung Ho Her; Jon Suh; Min Woong Kim; Yeo Joo Kim; Hwan Jun Choi; Jae Wan Soh
Journal:  Trials       Date:  2014-09-10       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.